Vascular pericyte density and angiogenesis associated with adenocarcinoma of the prostate

Pathobiology

Volumn 78, Issue 1, 2011, Pages 24-34

  Killingsworth, Murray C ^a,b,c   Wu, Xiaojuan ^a,c  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Adenocarcinoma; Angiogenesis; Pericyte; Prostate

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN;

ARTICLE; CARCINOGENESIS; CELL COUNT; CELL DENSITY; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELLULAR DISTRIBUTION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PERICYTE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; VASCULARIZATION;

ADENOCARCINOMA; CELL COUNT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 79953881754     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322739     Document Type: Article

References (49)

1. Bergers G, Song S: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-464. (Pubitemid 41555617)
2. Adams RH, Alitalo K: Molendothelial cellular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007; 8:464-478. (Pubitemid 46823443)
3. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA: Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994; 73: 678-687. (Pubitemid 24046612)
4. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-409. (Pubitemid 24058195)
5. Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de Torres I: Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol 2006; 21: 857-865. (Pubitemid 44082728)
6. Weidner N: Editorial: Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998; 184: 119-122.
7. Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK: Molecular markers and death from prostate cancer. Ann Intern Med 2009; 150: 595-603.
8. Chodak GW, Warren KS: Watchful waiting for prostate cancer: a review article. Prostate Cancer Prostatic Dis 2006; 9: 25-29. (Pubitemid 43378864)
9. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-269. (Pubitemid 46486616)
10. Sivridis E, Giatromanolaki A, Koukourakis MI: The vascular network of tumors - what is it not for? J Pathol 2003; 201: 173-180. (Pubitemid 37258927)
11. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere M, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL: The hypoxia-inducible factor- pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117: 1616-1626.
12. Tozer GM, Lewis S, Michalowski A, Aber V: The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma. Br J Cancer 1990; 61: 250-257. (Pubitemid 20058284)
13. Allsbrook WC Jr, Simms WW: Histochemistry of the prostate. Hum Pathol 1992; 23: 297-305.
14. Weidner N, Semple JP, Wech WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
15. Borre M, Offersen BV, Nerstrom B, Overgaard J: Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78: 940-944. (Pubitemid 28430025)
16. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Rapid communication: tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168: 257-262.
17. Sharma S, Sharma MC, Sarkar C: Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005: 46: 481-489. (Pubitemid 40632304)
18. American Joint Committee on Cancer: Prostate; in Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds): AJCC Cancer Staging Manual, ed 6. Berlin, Springer, 2002, pp 309-313.
19. Jain RK: Molecular regulation of vessel maturation. Nat Med 2003; 9: 685-693. (Pubitemid 36749217)
20. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977; 14: 53-65. (Pubitemid 8153798)
21. Nehls V, Denzer K, Drenckhahn D: Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 1992; 270: 469-474.
22. Killingsworth MC: Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1995; 233: 313-323.
23. Ozerdem U, Stallcup WB: Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 2003; 6: 241-249. (Pubitemid 38506669)
24. Reynolds LP, Grazul-Bilska AT, Redmer DA: Angiogenesis in the corpus luteum. Endocrine 2000; 12: 1-9. (Pubitemid 30333803)
25. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE: Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009; 114: 5091-5101.
26. Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, Peault B: Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 2009; 20: 429-434.
27. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B: Perivascular mulipotent progenitor cells in human organs. Ann NY Acad Sci 2009; 1176: 118-123.
28. Diaz-Flores L, Gutierrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martin-Vassallo P, Diaz-Flores L Jr: Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24: 909-969.
29. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB: NG2 proteoglycan is expressed by mural cells during vascular morphogenesis. Dev Dyn 2001; 222: 218-227. (Pubitemid 32937594)
30. Verbeek MM, Otte-Holler I, Wesseling P, Ruiter DJ, de Waal RMW: Induction of - smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-1. Am J Pathol 1994; 144: 372-382.
31. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G: PDGFR + perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005; 7: 870-879. (Pubitemid 41486287)
32. Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y: Overexpression of platelet- derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1 CXCR4 axis. Cancer Res 2009; 69: 6057-6064.
33. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003; 111: 1287-1295. (Pubitemid 36554699)
34. Greenberg JI, Cheresh DA: VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opin Biol Ther 2009; 9: 1347-1356.
35. Helfrich I, Scheffrahn I, Bartling S, Weis J, von Felbert V, Middleton M, Kato M, Ergun S, Schadendorf D: Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med 2010; 207: 491-503.
36. Hellberg C, Ostman A, Heldin CH: PDGF and vessel maturation. Recent Results Cancer Res 2010; 180: 103-114.
37. Ozerdem U: Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Prostate 2006; 66: 294-304. (Pubitemid 43191229)
38. Livanainen E, Lauttia S, Zhang N, Tvorogov D, Kulmala J, Grenman R, Salven P, Elenius K: The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrowderived perivascular cells into tumor vessels. Microvasc Res 2009; 78: 278-285.
39. Vartanian RK, Weidner N: Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density and epithelial cell proliferation. Lab Invest 1995; 73: 844-850. (Pubitemid 26002344)
40. Seigal JA, Brawer MK: Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75: 2545-2551.
41. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364. (Pubitemid 26272076)
42. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-410. (Pubitemid 37328844)
43. Soares AB, Juliano PB, Araujo VC, Metze K, Altemani A: Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma. Virchows Arch 2007; 451: 65-71.
44. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002; 160: 985-1000. (Pubitemid 34224587)
45. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314: 15-23. (Pubitemid 37409909)
46. Guillemin GJ, Brew BJ: Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukocyte Biol 2004; 75: 388-397. (Pubitemid 38316367)
47. Kruger M, Bechmann I: CNS pericytes: concepts, misconceptions, and a way out. Glia 2010; 58: 1-10.
48. Schlingemann RO, Rietveld FJR, de Waal RMW, Ferrone S, Ruiter DJ: Expression of the high molendothelial cellular weight melanoma- associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol 1990; 136: 1393-1405. (Pubitemid 20210338)
49. Orlidge A, D'Amore PA: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987; 105: 1455-1462. (Pubitemid 18029870)